Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

GNTA vs DSCO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GNTA Wins Head-to-Head Institutional Verdict (2–1 across 6 Pillars · 6–2 Matrix Metrics)

GNTA Overall Winner 6-Pillar Tally: GNTA 2 – 1 DSCO (3 Tie) Matrix Metrics: GNTA 6 – 2 DSCO

As of Nov 16, 2026, Genenta Science S.p.A. (GNTA) is the stronger overall head-to-head candidate over DSCO (DSCO) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 2–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). GNTA carries a Unified Composite Score of 35.3/100 (SELL) at $0.98 (N/M Forward P/E, 0.0% operating margin), whereas DSCO carries 39.5/100 (SELL) at $24.29 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While DSCO currently prints a higher short-term Unified Composite Score (39.5/100 SELL vs. GNTA 35.3/100 SELL), GNTA captures the overall institutional head-to-head verdict (6–2 matrix metrics and 2–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. N/A operating margin) and revenue trajectory (+0.0% vs. N/A YoY).
  • Defensive Composite Rating Caution: Although GNTA compares more favorably head-to-head, both GNTA (35.3/100 SELL) and DSCO (39.5/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: GNTA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 71.6); meanwhile DSCO is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 36.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GNTA vs DSCO
GNTA NASDAQ Head-to-Head Winner
Genenta Science S.p.A. American Depositary Shares
Biological Products, (No Diagnostic Substances)
$0.98
+20.62% 1D
Market Cap $39.4M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.45β · 132% Vol
Unified Composite Score
35.3 / 100 SELL
Tech 15.0 Fund 36.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 72
RSI-14: 71.6 · SMA20: $0.69 · SMA50: $0.78
DSCO US Equity
DSCO
Institutional Equity
$24.29
-0.21% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.03β · 2% Vol
Unified Composite Score
39.5 / 100 SELL
Tech 32.0 Fund 50.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.6%) with fading momentum, RSI 37
RSI-14: 36.8 · SMA20: $24.39 · SMA50: $24.42

6-Pillar Scorecard Institutional Category Breakdown (GNTA 2 – 1 DSCO)

Columns: Metric · GNTA · DSCO
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale GNTA
Revenue Growth (YoY) +0.0% N/A
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) N/A N/A
Market Cap $39.4M N/A
3. Profitability & Quality GNTA
Gross Margin N/A N/A
Operating Margin 0.0% N/A
Net Profit Margin 0.0% N/A
Return on Equity (ROE) -38.0% N/A
4. Balance Sheet & Cash Flow DSCO
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $1.05 Book/Sh · -38.0% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew Thin ADR Chain N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Distribution
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Conglomerates Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GNTA (6) vs DSCO (2)
Institutional Metric GNTA DSCO Criterion Row Edge
Market Capitalization
Scale
$39.4M N/A Larger Scale GNTA
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% N/A Higher Growth GNTA
Operating Margin (TTM)
Profitability
0.0% N/A Higher Margin GNTA
Net Profit Margin
Profitability
0.0% N/A Higher Margin GNTA
Return on Equity (ROE)
Capital Efficiency
-38.0% N/A Higher ROE GNTA
52-Week Range Position
Momentum
18% ($1–$3) 14% ($24–$25) Stronger Trend GNTA
Beta / 30D Volatility
Risk Regime
1.45β · 132% Vol 0.03β · 2% Vol Lower Realized Risk DSCO
Unified Institutional Score
Composite Signal
35.3 / 100 (SELL) 39.5 / 100 (SELL) Higher Composite DSCO
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($1.05 Book/Sh · -38.0% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GNTA +34.59 pp
GNTA: +34.93% · DSCO: +0.34%
3M Horizon DSCO +24.38 pp
GNTA: -25.94% · DSCO: -1.56%
6M Horizon GNTA +48.71 pp
GNTA: +47.01% · DSCO: -1.7%
1Y Horizon GNTA +2.59 pp
GNTA: -0.01% · DSCO: -2.6%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNTA vs DSCO. Trailing 12-month operating profitability (GNTA 0.0% vs DSCO N/A) and valuation multiples (GNTA N/M vs DSCO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

GNTA ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-38.0% · N/M
DSCO ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GNTA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GNTA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
DSCO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DSCO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GNTA Moat Profile Cyclical / Execution-Driven Positioning
Conglomerates Operator
Competes within the Conglomerates value chain with $39.4M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
DSCO Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ GNTA vs DSCO Key Questions & Quantitative Answers

As of Nov 16, 2026, Genenta Science S.p.A. (GNTA) is the stronger overall head-to-head candidate over DSCO (DSCO) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 2–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). GNTA carries a Unified Composite Score of 35.3/100 (SELL) at $0.98 (N/M Forward P/E, 0.0% operating margin), whereas DSCO carries 39.5/100 (SELL) at $24.29 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While DSCO currently prints a higher short-term Unified Composite Score (39.5/100 SELL vs. GNTA 35.3/100 SELL), GNTA captures the overall institutional head-to-head verdict (6–2 matrix metrics and 2–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. N/A operating margin) and revenue trajectory (+0.0% vs. N/A YoY). Defensive Composite Rating Caution: Although GNTA compares more favorably head-to-head, both GNTA (35.3/100 SELL) and DSCO (39.5/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: GNTA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 71.6); meanwhile DSCO is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 36.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GNTA leads the Growth & Scale pillar: GNTA posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with DSCO at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, GNTA generates N/A in USD-normalized revenue versus N/A for DSCO. In operating R&D and SG&A reinvestment, GNTA deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for DSCO.

GNTA and DSCO trade at balanced relative valuation multiples. GNTA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas DSCO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GNTA (-38.0% ROE) versus DSCO (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, GNTA carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.45β · 132% Vol realized risk). By comparison, DSCO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.03β · 2% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.